未登录

M

Michal Douša

Sanofi-Aventis

H指数:21

被引数:1,097

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comprehensive UHPLC-MS screening methods for the analysis of triazolopyrazine precursor and its genotoxic nitroso-derivative in sitagliptin pharmaceutical formulation

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2024-01-014

PRE

What is the role of current mass spectrometry in pharmaceutical analysis?

MASS SPECTROMETRY REVIEWS

IF6.6

2023-07-2813

OA

Analytical Quality by Design-Compliant Development of a Cyclodextrin-Modified Micellar ElectroKinetic Chromatography Method for the Determination of Trimecaine and Its Impurities

IF4.6

2023-06-134

OAAI

N-Nitrosation in the absence of nitrosating agents in pharmaceuticals?

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2022-09-0115

PRE

Nitrites as precursors of N-nitrosation in pharmaceutical samples - A trace level analysis

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2022-05-017

PRE

The determination of two analogues of 4-(azidomethyl)-1,1′-biphenyl as potential genotoxic impurities in the active pharmaceutical ingredient of several sartans containing a tetrazole group

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2021-10-0113

PREAI

Analytical quality by design in the development of a solvent-modified micellar electrokinetic chromatography method for the determination of sitagliptin and its related compounds

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2021-08-0116

PREAI

Insight into the formation of N-nitrosodimethylamine in metformin products

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2021-02-0123

PREAI

HILIC-MS determination of dimethylamine in the active pharmaceutical ingredients and in the dosage forms of metformin

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2020-11-0112

PREAI

Detection and structure elucidation of the new degradation impurities in the pharmaceutical formulations of ruxolitinib hydrobromide

氢溴酸鲁索替尼制剂中新降解杂质的检测和结构解析

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2020-07-013

PREAI

Quality by Design as a risk-based strategy in pharmaceutical analysis: Development of a liquid chromatography-tandem mass spectrometry method for the determination of nintedanib and its impurities

JOURNAL OF CHROMATOGRAPHY A

IF4

2020-01-0125

PREAI

Enantioseparation of N-acetyl-DL-cysteine as o-phtaldialdehyde derivatives obtained with various primary aliphatic amine additives on polysaccharide-based chiral stationary phases

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2019-03-016

PREAI

Quantification of 2-aminoisobutyric acid impurity in enzalutamide bulk drug substance using hydrophilic interaction chromatography with fluorescence detection

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2019-02-014

PREAI

Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2019-01-017

PREAI

Chiral capillary zone electrophoresis in enantioseparation and analysis of cinacalcet impurities: Use of Quality by Design principles in method development

JOURNAL OF CHROMATOGRAPHY A

IF4

2018-09-0134

OAAI

The determination of pharmaceutically active thiols using hydrophilic interaction chromatography followed postcolumn derivatization with o-phthaldialdehyde and fluorescence detection

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2018-07-0112

PREAI

HPLC/UV/MS method application for the separation of obeticholic acid and its related compounds in development process and quality control

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2018-02-018

PREAI

General screening and optimization strategy for fast chiral separations in modern supercritical fluid chromatography

现代超临界流体色谱中快速手性分离的一般筛选和优化策略

ANALYTICA CHIMICA ACTA

IF6

2017-01-0166

PREAI

Enantioseparation and impurity determination of ambrisentan using cyclodextrin-modified micellar electrokinetic chromatography: Visualizing the design space within quality by design framework

JOURNAL OF CHROMATOGRAPHY A

IF4

2016-10-0138

PREAI

A novel approach for HPLC determination of 2-cynaoacetamide using derivatization procedure with 2-hydroxyacetophenone as a new useful derivatization reagent

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2016-09-016

PREAI